A recent Kentucky.com (Lexington Herald-Leader) editorial expressed support for passing legislation to “limit meth labs” by forcing law abiding Kentuckians to obtain a prescription for the purchase of medicines with pseudoephederine.
This ineffective approach to the state’s drug problem was hopefully put to rest for the duration of the 2012 General Assembly.
There was an interesting quote in the Kentucky.com editorial…
The opposition to these efforts is driven by a powerful and wealthy group representing the pharmaceutical companies producing medications containing pseudoephedrine.
The Courier-Journal reported Tuesday that in January the Consumer Healthcare Products Association spent $194,957.56 lobbying the legislature, five times as much as any other lobbying group.
Transparency in our government, in this case the legislative process, is very important. Money and its origin is a very important aspect of transparency.
I look forward to reading more about transparency and specific dollar amounts in Kentucky.com and The Lexington Herald-Leader editorials for legislation they support, not just those they oppose. That’s only fair, right?